2[2]Chobanian AV,Bakris GL,Black HR,et al.The seventh report of the joint national committee on prevention,detection,evaluation,and treatment of high blood pressure:the JNC 7 report[J].JAMA,2003,289:2560-2572.
3[3]Kimura B,Mohuczy D,Tang X,et al.Attenuation of hypertension and heart hypertrophy by adeno-associated virus delivering angiotensinogen antisense[J].Hypertens,2001,37:376-380.
7[7]Wang X,Skelley L,Cade R,et al.AAV delivery of mineralocorticoid receptor shRNA prevents progression of cold-induced hypertension and attenuates renal damage[J].Gene Ther,2006,13:1097-103.
8[8]Modlinger P,Chabrashvili T,Pritomhinder S,et al.RNA silencing in vivo reveals role of p22phox in rat angiotensin slow pressor response[J].Hypertens,2006,47:238-244.
7Brand E, Chatelain N, Paillard F, et al. Detection of putative functional angiotensinogen (AGT) gene variants controlling p las- rna AGT levels by combinedsegregation linkage analysis [J]. Eur J Hum Genet, 2002,10 ( 11 ) : 715-723.
8Sethi AA, Nordestgaard BG, GronholdMt L, et al. Angio- tensinogen single nucleotide polymorphisms, elevated blood pres- sure, and risk of cardiovas-cular disease [ J ]. Hypertension, 2003,41(6) : 1202-1211.
9Zou GY, Dormer A. The merits of testing Hardy-Weinberge quilibrium in the Analysis of unmatched case-control data: a cau- tionary note [J]. Ann Hum Genet, 2006,70(6):923-933.
10Yuan J, Tang W, Chun Y, et M, Angiotensinogen T174M and M235T Variants and Hypertension in the Hani and Yi Minority Groups of China [J ]. Biochem Genet, 2009,47:344-350.
